SCHEMBL4288403

SCHEMBL4288403

CCOc1ccc(C(=O)C2=C(Cl)CC(C)CC2=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.46
KMT2A Q03164 1/20 0.46
PARP10 Q53GL7 1/20 0.43
MAPK1 P28482 2/20 0.43
LMNA P02545 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
HPGD P15428 4/20 0.42
KDM4E B2RXH2 4/20 0.42
MAPT P10636 3/20 0.42
NPC1 O15118 3/20 0.42
ALDH1A1 P00352 3/20 0.42
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 2/20 0.42
RAB9A P51151 2/20 0.42
RECQL P46063 1/20 0.42
TSHR P16473 1/20 0.42
PLK1 P53350 1/20 0.41
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4287440 0.86 KMT2A (0.47) NPSR1KMT2APARP10MAPK1LMNA
SCHEMBL4285306 0.85 HPGD (0.50) NPSR1KMT2APARP10MAPK1LMNA
SCHEMBL4288581 0.85 KMT2A (0.46) NPSR1KMT2APARP10MAPK1LMNA
SCHEMBL4285657 0.85 PARP10 (0.40) PARP10
SCHEMBL15133265 0.80 TPMT (0.34)
SCHEMBL18227973 0.79 PLA2G1B (0.40) NPSR1KMT2AMAPK1LMNAL3MBTL1
SCHEMBL4288353 0.75 L3MBTL1 (0.44) KMT2AMAPK1LMNAL3MBTL1HPGD
SCHEMBL845348 0.72 NPSR1 (0.79) NPSR1KMT2APARP10MAPK1LMNA
SCHEMBL4279762 0.70 LMNA (0.45) NPSR1KMT2APARP10MAPK1LMNA
SCHEMBL4284546 0.70 LMNA (0.45) NPSR1KMT2APARP10MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 NPSR1 1569/4885KMT2A 1397/4885PARP10 2557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.